DNA damage from hydroxyurea therapy-variable-diversity-joining (VDJ) recombination events defined as the number of events per microgram of genomic DNA; Every 3 years [clinicaltrials_resource:fef556f45049086f2c7bfebbbfa81019]
optional test
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
DNA damage from hydroxyurea therapy-variable-diversity-joining (VDJ) recombination events defined as the number of events per microgram of genomic DNA; Every 3 years [clinicaltrials_resource:fef556f45049086f2c7bfebbbfa81019]
optional test
Bio2RDF identifier
fef556f45049086f2c7bfebbbfa81019
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fef556f45049086f2c7bfebbbfa81019
measure [clinicaltrials_vocabulary:measure]
DNA damage from hydroxyurea th ...... per microgram of genomic DNA;
time frame [clinicaltrials_vocabulary:time-frame]
Every 3 years
description
optional test
identifier
clinicaltrials_resource:fef556f45049086f2c7bfebbbfa81019
title
DNA damage from hydroxyurea th ...... of genomic DNA; Every 3 years
@en
type
label
DNA damage from hydroxyurea th ...... 556f45049086f2c7bfebbbfa81019]
@en